Robert W. Duggan Purchases 150,123 Shares of Pulse Biosciences Inc (PLSE) Stock

Pulse Biosciences Inc (NASDAQ:PLSE) major shareholder Robert W. Duggan bought 150,123 shares of the firm’s stock in a transaction dated Wednesday, April 19th. The stock was purchased at an average price of $23.77 per share, for a total transaction of $3,568,423.71. Following the transaction, the insider now owns 2,601,850 shares of the company’s stock, valued at $61,845,974.50. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Robert W. Duggan also recently made the following trade(s):

  • On Monday, April 10th, Robert W. Duggan bought 191,464 shares of Pulse Biosciences stock. The stock was purchased at an average price of $19.75 per share, for a total transaction of $3,781,414.00.

Pulse Biosciences Inc (NASDAQ:PLSE) opened at 25.42 on Friday. The stock’s market cap is $359.34 million. The stock has a 50 day moving average price of $22.46 and a 200 day moving average price of $10.90. Pulse Biosciences Inc has a 52-week low of $4.03 and a 52-week high of $35.93.

TRADEMARK VIOLATION NOTICE: “Robert W. Duggan Purchases 150,123 Shares of Pulse Biosciences Inc (PLSE) Stock” was published by WKRB News and is the property of of WKRB News. If you are accessing this piece on another website, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this piece can be viewed at http://www.wkrb13.com/markets/2066269/robert-w-duggan-purchases-150123-shares-of-pulse-biosciences-inc-plse-stock.html.

Pulse Biosciences Company Profile

Pulse Biosciences, Inc, formerly Electroblate, Inc, is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue.

5 Day Chart for NASDAQ:PLSE

This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/2066269/robert-w-duggan-purchases-150123-shares-of-pulse-biosciences-inc-plse-stock.html

Receive News & Ratings for Pulse Biosciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences Inc and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.